Novo Integrated Sciences Return on Tangible Equity 2012-2024 | NVOS

Current and historical return on tangible equity values for Novo Integrated Sciences (NVOS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Novo Integrated Sciences Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-02-29 $-0.01B $-0.00B -2400.00%
2023-11-30 $-0.01B $0.00B -1120.00%
2023-08-31 $-0.01B $0.00B inf%
2023-05-31 $-0.03B $0.00B 2133.33%
2023-02-28 $-0.04B $0.00B 2000.00%
2022-11-30 $-0.04B $-0.01B 2000.00%
2022-08-31 $-0.03B $-0.01B 13200.00%
2022-05-31 $-0.01B $0.00B -866.67%
2022-02-28 $-0.01B $0.00B -257.14%
2021-11-30 $-0.01B $0.00B -142.86%
2021-08-31 $-0.00B $0.00B -106.67%
2021-05-31 $-0.01B $0.01B -160.00%
2021-02-28 $-0.01B $0.00B -300.00%
2020-11-30 $-0.01B $0.00B -300.00%
2020-08-31 $-0.01B $0.00B -222.22%
2020-05-31 $-0.00B $0.00B -40.00%
2020-02-29 $-0.00B $0.00B -40.00%
2019-11-30 $0.00B $0.00B 0.00%
2019-08-31 $0.00B $0.00B 0.00%
2019-05-31 $0.00B $0.00B 0.00%
2019-02-28 $0.00B $0.00B 0.00%
2018-11-30 $-0.00B $0.00B inf%
2018-08-31 $-0.00B $0.00B 80.00%
2018-05-31 $-0.00B $0.00B 80.00%
2018-02-28 $-0.00B $0.00B 53.33%
2017-11-30 $-0.00B $-0.01B 26.67%
2017-08-31 $-0.00B $-0.01B 40.00%
2017-03-31 $0.00B $0.00B nan%
2017-02-28 $0.00B nan%
2016-11-30 $0.00B nan%
2016-09-30 $0.00B $0.00B nan%
2016-05-31 $0.00B nan%
2016-03-31 $0.00B $0.00B nan%
2015-06-30 $-0.00B $0.00B 800.00%
2015-03-31 $-0.00B $0.00B 400.00%
2014-06-30 $0.00B $-0.00B 0.00%
2014-03-31 $0.00B $-0.00B 0.00%
2013-09-30 $0.00B $-0.00B 0.00%
2013-06-30 $0.00B $-0.00B 0.00%
2012-12-31 $0.00B $-0.00B 0.00%
2012-09-30 $0.00B $-0.00B 0.00%
2012-03-31 $-0.00B $-0.00B 100.00%
2012-02-29 $-0.00B $0.00B 400.00%
2011-11-30 $-0.00B inf%
2011-09-30 $-0.00B inf%
2011-08-31 $-0.00B inf%
2011-06-30 $-0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.011B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.827B 10.78
Quest Diagnostics (DGX) United States $16.063B 16.60
DaVita (DVA) United States $11.923B 14.81
Encompass Health (EHC) United States $8.608B 22.03
Chemed (CHE) United States $8.132B 25.20
Elanco Animal Health (ELAN) United States $6.597B 17.11
Option Care Health (OPCH) United States $5.235B 19.82
RadNet (RDNT) United States $4.632B 96.45
Amedisys (AMED) United States $3.202B 22.68
Astrana Health (ASTH) United States $2.666B 36.05
Addus HomeCare (ADUS) United States $2.179B 28.20
LifeStance Health (LFST) United States $2.095B 0.00
U.S Physical Therapy (USPH) United States $1.424B 38.10
Pennant (PNTG) United States $0.789B 41.67
Aveanna Healthcare Holdings (AVAH) United States $0.677B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00